Suppr超能文献

β1整合素和KV1.3通道依赖性信号传导刺激Th17细胞释放谷氨酸。

β1-Integrin- and KV1.3 channel-dependent signaling stimulates glutamate release from Th17 cells.

作者信息

Birkner Katharina, Wasser Beatrice, Ruck Tobias, Thalman Carine, Luchtman Dirk, Pape Katrin, Schmaul Samantha, Bitar Lynn, Krämer-Albers Eva-Maria, Stroh Albrecht, Meuth Sven G, Zipp Frauke, Bittner Stefan

机构信息

Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2, ), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Department of Neurology, University of Muenster, Muenster, Germany.

出版信息

J Clin Invest. 2020 Feb 3;130(2):715-732. doi: 10.1172/JCI126381.

Abstract

Although the impact of Th17 cells on autoimmunity is undisputable, their pathogenic effector mechanism is still enigmatic. We discovered soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE) complex proteins in Th17 cells that enable a vesicular glutamate release pathway that induces local intracytoplasmic calcium release and subsequent damage in neurons. This pathway is glutamine dependent and triggered by binding of β1-integrin to vascular cell adhesion molecule 1 (VCAM-1) on neurons in the inflammatory context. Glutamate secretion could be blocked by inhibiting either glutaminase or KV1.3 channels, which are known to be linked to integrin expression and highly expressed on stimulated T cells. Although KV1.3 is not expressed in CNS tissue, intrathecal administration of a KV1.3 channel blocker or a glutaminase inhibitor ameliorated disability in experimental neuroinflammation. In humans, T cells from patients with multiple sclerosis secreted higher levels of glutamate, and cerebrospinal fluid glutamine levels were increased. Altogether, our findings demonstrate that β1-integrin- and KV1.3 channel-dependent signaling stimulates glutamate release from Th17 cells upon direct cell-cell contact between Th17 cells and neurons.

摘要

尽管Th17细胞对自身免疫的影响是无可争议的,但其致病效应机制仍然神秘莫测。我们在Th17细胞中发现了可溶性N - 乙基马来酰亚胺敏感因子附着受体(SNARE)复合蛋白,该蛋白促成了一种囊泡性谷氨酸释放途径,可诱导局部胞浆内钙释放并随后对神经元造成损伤。此途径依赖谷氨酰胺,并由炎症环境中β1整合素与神经元上的血管细胞黏附分子1(VCAM - 1)结合触发。抑制谷氨酰胺酶或KV1.3通道可阻断谷氨酸分泌,已知这两种物质与整合素表达相关且在活化的T细胞上高度表达。虽然KV1.3不在中枢神经系统组织中表达,但鞘内注射KV1.3通道阻滞剂或谷氨酰胺酶抑制剂可改善实验性神经炎症中的功能障碍。在人类中,多发性硬化症患者的T细胞分泌更高水平的谷氨酸,且脑脊液谷氨酰胺水平升高。总之,我们的研究结果表明,在Th17细胞与神经元直接细胞 - 细胞接触时,β1整合素和KV1.3通道依赖性信号传导刺激Th17细胞释放谷氨酸。

相似文献

引用本文的文献

6
Metabolic footprint and logic through the T cell life cycle.代谢足迹与 T 细胞生命周期的逻辑。
Curr Opin Immunol. 2024 Dec;91:102487. doi: 10.1016/j.coi.2024.102487. Epub 2024 Sep 21.
8
The neuropathobiology of multiple sclerosis.多发性硬化的神经病理学。
Nat Rev Neurosci. 2024 Jul;25(7):493-513. doi: 10.1038/s41583-024-00823-z. Epub 2024 May 24.
10
Implications of immunometabolism for smouldering MS pathology and therapy.免疫代谢对 MS 静息期病理和治疗的影响。
Nat Rev Neurol. 2023 Aug;19(8):477-488. doi: 10.1038/s41582-023-00839-6. Epub 2023 Jul 10.

本文引用的文献

2
Glutamate, T cells and multiple sclerosis.谷氨酸、T细胞与多发性硬化症
J Neural Transm (Vienna). 2017 Jul;124(7):775-798. doi: 10.1007/s00702-016-1661-z. Epub 2017 Feb 24.
7
Antiglutamatergic therapy for multiple sclerosis?用于治疗多发性硬化症的抗谷氨酸能疗法?
Lancet Neurol. 2016 Sep;15(10):1003-4. doi: 10.1016/S1474-4422(16)30163-6. Epub 2016 Aug 8.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验